ICH M7 Knowledge and Data Sources Management
Transcript of ICH M7 Knowledge and Data Sources Management
Scope
• Sources of Data and Knowledge for ICH M7
Assessments
• Knowledge Management for ICH M7 Assessments
Scope
• Sources of Data and Knowledge for ICH M7
Assessments
• Knowledge Management for ICH M7 Assessments
Sources of Data and Knowledge – ICH M7
• Public Databases
• Literature Searches
• In Silico Tools
• In-house Databases
• Shared knowledge
• Shared Data
Sources of Data and Knowledge – ICH M7
• Public Databases
• Literature Searches
• In Silico Tools
• In-house Databases
• Shared knowledge
• Shared Data
Shared Knowledge for ICH M7
• Lhasa Aim – Predict mutagenicity for all chemical space
• To achieve this proprietary data needs to be used for
refinement of Derek Nexus mutagenicity alerts, public
data sources are not enough.
• Over the last 20 years a lot of proprietary in-house
mutagenicity data has been shared
• Result – 33% of Derek mutagenicity alerts have been
developed and/or modified using proprietary data
• Validations can also be carried out using proprietary data
KNOWLEDGE SHARING
Using proprietary data to
generate new/modify
mutagenicity alerts
Mutagenicity in Derek Nexus
Metrics (%) Results
Data
setSe Sp PP NP Acc TP FP TN FN Total
Public 83 75 79 79 79 2908 762 2247 595 6512
• 132 alerts for mutagenicity
• Comprehensive coverage of endpoint• Aromatic amines and boronic acids are still of significant interest
and require refinement
• Derek Nexus performance against public data is very good
Member data set - Performance
• 1,261 compounds
• Mainly negative results• Bias = 77% negative
• 114 FP
• 117 FN
Mutagenicity
Metrics (%) Results
Data
setSe Sp PP NP Acc TP FP TN FN Total
Public 83 75 79 79 79 2908 762 2247 595 6512
Member 59 88 60 88 82 168 114 862 117 1261
Member data set – New/Modified alert summary
• 5 new alerts
• Amine (x4)
• Boronic acid
• 4 modifications to existing alerts
• Azide, hydrazoic acid or azide salt
• Alkyl aldehyde
• Arylhydrazine
• Arylboronic acid or derivative
• 4 potential new alerts/alert modifications
• Requires more data/mechanistic support
Results – Member data - Mutagenicity
Results – Public data - Mutagenicity
Placeholder Japanese Data Sharing
• Info to be provided Friday 3rd May
DATA SHARING for ICH M7
Data Sharing
• Synthetic Intermediates – Ames Data
• 1,587 Structures – 26,592 records
• Aromatic Amines - Ames Data
• 778 structures – 11,280 records
Use of Shared Data sets
• Data Source• Avoid repeat testing
• Use within regulatory submission
• Make decisions/help to prioritise
• Validation of in silico tools• By Lhasa, Industry and Regulators
• Improvement of in silico tools
• Shared understanding
Scope
• Sources of Data and Knowledge for ICH M7
Assessments
• Knowledge Management for ICH M7 Assessments
ICH M7 Workflow
• Is there any public data?
• Is there any in-house data or shared data?
• What do the in silico systems say?
• If there are any concerns, are they more concerning than the API itself
• What do you think as an expert? Can you add more knowledge?
• Should you test (Ames), control, limit according to TTC or make an argument for Purge?
• Where can I store my expert decision and supporting
information?• For submission
• For future reference
Setaria: Integrated ICH M7 Workflow Tool
Gathering Evidence
and Arriving at a
Conclusion
Storing
Assessments in a
Searchable Way
Gathering Evidence
ICH M7 Assessment
Experimental Data
Public Carc Study Data
Public Mut Study Data
Data Sharing Initiatives
In-House Data
in silicoPredictions Expert Rule
Based
Statistical Based
Expert Assessment
Storing Assessments
Searchable Storage of
Assessments: Crucial
Common impurities are
regularly assessed over
time
Multiple individuals completing
ICH M7 assessments
Need to assess the
performance of in silico tools
Setaria: Streamlining ICH M7 Workflow
Gathering Evidence
and Arriving at a
Conclusion
Storing
Assessments in a
Searchable Way
Searchable Storage of
Assessments: Crucial
Common impurities are
regularly assessed over
time
Multiple individuals
completing ICH M7
assessments
Need to assess the
performance of in silico tools
Setaria: Streamlining ICH M7 Workflow
Previously Reviewed
Reassess and
Document
Cmpd
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Setaria: Streamlining ICH M7 Workflow
Pulling all ICH M7 appropriate information into a single repository means easier, less time consuming, and less
costly assessments
Exposing full assessments reduces the likelihood of duplicating effort between individuals and teams over time, and provides an insight into the impact of further
testing on other projects
Extensive and flexible searching facilitates review of conflicting in silico predictions and assay results, allowing the directed sharing of data to improve predictions for in-
house chemical space
Single Point
of Truth per
Compound
Project
Centric
Storage
Improve
Performance
of in silico
“Setaria saves significant time when searching
for genotoxicity findings and has delivered improved
visibility of our data across the business.”
Jim Harvey, Head of Computational Toxicology at GSK
Lhasa Limited
Granary Wharf House, 2 Canal Wharf
Leeds, LS11 5PS
Registered Charity (290866)
Company Registration Number 01765239
+44(0)113 394 6020
www.lhasalimited.org
Shared Data and Knowledge provides a very
important source of additional information for ICH
M7 Assessments
A Knowledge management system can be useful
for managing results from an ICH M7 Workflow
Conclusions